Skip to main content
Clinical Trials/CTRI/2024/05/068178
CTRI/2024/05/068178
Not yet recruiting
未知

Assessment of visual performance of a new panfocal intraocular lens for visual quality and safety (Naturo, Caregroup, SS Pvt. Ltd.) - Nil

Caregroup, SS Pvt Ltd0 sites0 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
Caregroup, SS Pvt Ltd
Status
Not yet recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Observational

Investigators

Sponsor
Caregroup, SS Pvt Ltd

Eligibility Criteria

Inclusion Criteria

  • 1\. Patient with bilateral age related senile cataract
  • 2\. grade of cataract permitting optical biometry
  • 3\. no ocular/systemic contraindication for surgery
  • 4\. a patient with preoperative corneal astigmatism less than 1D in each eye
  • 5\. normal macular functions with normal anantomy of macula as seen on optical coherence tomography
  • 6\. no history or evidence of ocular anatomical or functional disorders other than cataract including strabismus neuro\-ophthalmological disorders of optic nerve or high visual functions corneal pathologies disorders of uvea vitreous pathologies retinal disorders
  • 7\. no systemic contraindications to surgery under local anaesthesia
  • 8\. patient willing to undergo the investigations and comply with the follow\-up schedule

Exclusion Criteria

  • 1\. cataract precluding optical biometry
  • 2\. posterier\-segment pathology
  • 3\. media opacity other than cataract
  • 4\. corneal higher order aberrations more than 0\.3 micron as measured on ray\-tracing wavefront aberrometer
  • 5\. patients with potential for intraoperative complications such as floppy iris syndrome and pseudo\-exfoliation syndrome
  • 6\. cases where intra\-operative complications compromise IOL placement with proper centration in the capsule bag
  • 7\. patient unwilling to undergo the required investigations or follow\-up

Outcomes

Primary Outcomes

Not specified

Similar Trials